Miscategorization of Deaths in the US Food and Drug Administration Adverse Events Database
Author:
Affiliation:
1. Bates College, Lewiston, Maine
2. School of Medicine, University of California, San Francisco
3. Device Events, York, Pennsylvania
4. Department of Medicine, University of California, San Francisco
5. Editor, JAMA Internal Medicine
Publisher
American Medical Association (AMA)
Subject
Internal Medicine
Link
https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2752362/jamainternal_meier_2019_ld_190043.pdf
Reference6 articles.
1. Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices.;Dhruva;JAMA,2009
2. FDA flags inconsistent hospital reporting of medical device problems: hazy reporting rules beget confusion.;Barlas;P T,2017
3. The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies.;Carroll;J Am Coll Cardiol,2013
4. US Food and Drug Administration. Mandatory reporting requirements: manufacturers, importers and device user facilities. https://www.fda.gov/medicaldevices/deviceregulationandguidance/postmarketrequirements/reportingadverseevents/default.htm. Updated May 2, 2019. Accessed August 29, 2019.
5. Device Events. https://www.deviceevents.com/. Accessed April 20, 2019.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Assessing the Reproducibility of Research Based on the Food and Drug Administration Manufacturer and User Facility Device Experience Data;Journal of Patient Safety;2024-03-13
2. The Use and Utility of Food and Drug Administration Adverse Event Data from the Manufacturer and User Facility Device Experience Database in Otology: A Systematic Review;Otology & Neurotology;2023-05-31
3. Postmarket device safety monitoring;Translational Radiation Oncology;2023
4. Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death;JAMA Internal Medicine;2021-09-01
5. Fatalities possibly associated with hyaluronic acid injections: a review of events reported to the FDA;Drugs & Therapy Perspectives;2021-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3